Interview with Ala Ciobanu, General Manager, Roche Ukraine
As a leader responsible for heading Roche’s operations since its establishment of an LLC in Ukraine in 2009, what do you consider have been the main achievements of the company?…
Address: 19-21, Bogdana Khmelnitskogo str., 10th floor, 01030 Kiev,Ukraine
Tel: +380 44 354 3040
Web: http://www.roche.com/index.htm
Roche focuses on developing medicines and diagnostics that will help patients live longer, better lives.
Roche strives to address unmet medical needs through excellence in science – from early detection and prevention of diseases to diagnosis, treatment and treatment monitoring.
The activities of Roche in Ukraine began in 1998 when a representative office was opened; In 2009, Roche Ltd Ukraine was opened.
Pharmaceuticals – Roche has brought many highly effective drugs onto the market and is a world leader in innovative cancer drugs. Other areas include viral infections, metabolic, central nervous system disorders and inflammatory diseases.
Solutions for Diagnostics – As the world leader in in-vitro diagnostics, we supply a wide range of rapid, reliable instruments and tests for disease screening and diagnosis in laboratories, at the point of care, and for patient self-management. More
Products for Researchers – Roche Applied Science supplies a broad array of instruments and highly specific reagents and test kits for use in the diverse research market.
The portfolio is especially strong in genomics and proteomics. Mo
As a leader responsible for heading Roche’s operations since its establishment of an LLC in Ukraine in 2009, what do you consider have been the main achievements of the company?…
As the founder of SMD what was it the prompted you to create this company and what were your objectives at that time? Up until 2003 when I created SMD,…
What was the market need that spawned the creation of AIPM in 2009 considering that there were already other trade associations in Ukraine that were representing the interests of international…
Lekhim group was one of the pioneers for establishing a national pharmaceutical industry in 1992. This year you will be celebrating 20th anniversary. Would you start by providing us with…
As the first Ukrainian pharmaceutical company backed by foreign capital, explain to us how the idea of creating “Sperco Ukraine” as a joint-venture with UCRAFARMA emerged? The idea to create…
If you could provide our readers with your philosophy when you founded Sayenko Kharenko in 2004. What were the market needs that were perhaps missing that you identified and wanted…
It has been one year since you were appointed as the head of UCB’s operations in Ukraine. What was the mission of your assignment when you took this position and…
Considering you only took over as CEO from your father in 2009, what was the mandate that was given to you as new CEO of the company – including your…
Orion’s global strategy focuses on the CIS and Eastern European markets that still exhibit large growth potential and are expanding, despite a reverse trend for the rest of the industry.…
What were the factors that led to Sanofi’s decision to establish an LLC in 2009 in Ukraine, and how has it changed your operations? Most of the major foreign companies…
Ipsen has showed some very positive results worldwide in 2010 and so far this year, specifically in non-Western European markets that grew by 12% in 2010. How have the Ukrainian…
Since the establishment of Astellas’ predecessor Brocade in Russia in 1992, what has been Astellas’ evolution in Ukraine? Astellas has been present in Ukraine for 16 years, first as Yamanouchi…
See our Cookie Privacy Policy Here
